Condition
Melanoma Cancer
Total Trials
5
Recruiting
1
Active
2
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 85/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
2Total
P 1 (1)
P 2 (1)
Trial Status
Terminated1
Recruiting1
Active Not Recruiting1
Unknown1
Completed1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT03693014Phase 2Active Not Recruiting
A Study of Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint Inhibitors
NCT04152018Phase 1Terminated
Study of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors.
NCT06685562Recruiting
The 4D PICTURE Project: Evaluating Metro Mapping As a Method to Support Shared Decision Making in Oncology
NCT01703585Completed
Feasibility Study of Genomic Profiling Methods and Timing in Tumor Samples
NCT02879474UnknownPrimary
Study of Risk Factors and Clinical Characterization of Rapidly Growing Melanoma
Showing all 5 trials